Workshop on Cancer and Inflammation: Promise for Biological Therapy

Workshop Main Page   |   Program Purpose   |   Faculty   |   CME Information
Presentation Slides & Schedule   |   Photos   |   Published Documents

October 30, 2008
Westin Gaslamp Quarter Hotel
San Diego, CA

Presentation Slides & Schedule
Slides for select presentations below have been provided by the corresponding speaker for your convenience.
Please click the next to the speaker's name to log in to view the presentations.

Thursday, October 30, 2008
6:30 am - 6:00 pm	Registration Open
7:00 am - 8:00 am	Continental Breakfast
7:45 am - 7:50 am	Welcome and Introduction Bernard A. Fox, PhD, Earle A. Chiles Research Institute
7:50 am - 8:15 am	Keynote Address Michael Karin, PhD, University of California, San Diego
8:15 am - 11:30 am	State of the Science Plenary Sessions
8:15 am - 8:45 am	Defining Inflammation Co-Chairs: Michele Carbone, MD, PhD, Cancer Research Center of Hawaii  Sandra Demaria, MD, New York University
8:45 am - 9:15 am	Genetic Polymorphisms and Factors which Modulate Inflammation and Cancer Co-Chairs:  Yen-Ching Karen Chen, ScD, SM, National Taiwan University  Emad M. El-Omar, MB ChB, MD, University of Aberdeen
9:15 am - 9:45 am	Animal Models of Cancer and Inflammation Co-Chairs: Lisa M. Coussens, PhD, University of California, San Francisco Michael Karin, PhD, University of California, San Diego
9:45 am - 10:00 am	Break
10:00 am - 10:30 am	Causes and Molecular Targets in Cancer and Inflammation Co-Chairs: Michael T. Lotze, MD, University of Pittsburgh Cancer Institute Giorgio Trinchieri, MD, National Cancer Institute
10:30 am - 11:00 am	Current Clinical Evidence for Targeting Inflammation to Prevent Cancer Co-Chairs: Steven Dubinett, MD, University of California, Los Angeles  Eva Szabo, MD, National Cancer Institute, NIH
11:00 am - 11:30 am	Novel Therapeutics and Clinical Trial Development to Treat Cancer Co-Chairs:  Arthur M. Krieg, MD, Pfizer George J. Weiner, MD, University of Iowa
11:30 am - 12:00 pm	Lunch
12:00 pm - 1:30 pm	Concurrent Breakout Sessions (limited space available, pre-registration and ticket required)
	Breakout Session 1: Defining Inflammation Breakout Session 2: Genetic Polymorphisms and Factors which Modulate Inflammation and Cancer Breakout Session 3: Animal Models of Cancer and Inflammation. Breakout Session 4: Causes and Molecular Targets in Cancer and Inflammation Breakout Session 5. Current Clinical Evidence for Targeting Inflammation to Prevent Cancer Breakout Session 6. Novel Therapeutics and Clinical Trial Development to Treat Cancer
12:00 pm - 1:30 pm	Concurrent Group Lecture: Abstract Presentations Co-Chairs: George Coukos, MD, PhD, University of Pennsylvania Medical Center Ena Wang, MD, National Institutes of Health
12:00 pm - 12:15 pm	Recombinant Interleukin-21 Plus Sorafenib for Metastatic Renal Cell Carcinoma (MRCC): A Phase 1 Dose Escalation Study  Shailender Bhatia, MD, University of Washington
12:15 pm - 12:30 pm	The Genetic Background of IFNβ Responsiveness: A Genome-wide Study Zoltan Pos, PhD, National Institutes of Health
12:30 pm - 12:45 pm	Arginase I Producing Myeloid Derived Suppressor cells (MDSC) in Renal cell Carcinoma are a Sub Population of Activated Granulocytes Paulo C. Rodriguez, PhD, Louisiana State University Health Science Center
12:45 pm - 1:00 pm	RLIP76: A Target for Kidney cancer Therapy  Sanjay Awasthi, MD, University of North Texas Health Sciences Center
1:00 pm - 1:15 pm	Asbestos-Induced human Mesothelial Cell Death causes the Release if HMGBI abd Resultant Inflammation Haining Yang, PhD, Cancer Research Center of Hawaii, John A Burns School of Medicine
1:15 pm - 1:30 pm	April Produced by Neutrophils Promotes Diffuse Large B-Cell Lymphoma Development  Bertrand Huard, PhD, Medical University Center
1:30 pm - 2:00 pm	Break
2:00 pm - 2:30 pm	Plenary Session: Industry Perspectives on Anti-inflammatory Therapy Moderator: Bernard A. Fox, PhD, Earle A. Chiles Research Institute Speaker:  Robert T. Abraham, PhD, Wyeth
2:30 pm - 5:30 pm	Reporting Session/Panel Discussion Moderator: Michael T. Lotze, MD, University of Pittsburgh Cancer Institute
2:30 pm - 3:00 pm	Breakout 1 Report: Defining Inflammation  Michele Carbone, MD, PhD, Cancer Research Center of Hawaii
3:00 pm - 3:30 pm	Breakout 2 Report: Genetic Polymorphisms and Factors which Modulate Inflammation and Cancer  Emad M. El-Omar, MB ChB, MD, University of Aberdeen
3:30 pm - 4:00 pm	Breakout 3 Report: Animal Models of Cancer and Inflammation.  Lisa M. Coussens, PhD, University of California, San Francisco
4:00 pm - 4:30 pm	Breakout 4 Report: Causes and Molecular Targets in Cancer and Inflammation  Giorgio Trinchieri, MD, National Cancer Institute
4:30 pm - 5:00 pm	Breakout 5 Report: Current Clinical Evidence for Targeting Inflammation to Prevent Cancer  Steven Dubnielt, MD, University of california, Los Angeles
5:00 pm - 5:30 pm	Breakout 6 Report: Novel Therapeutics and Clinical Trial Development to Treat Cancer  George J. Weiner, MD, University of Iowa
5:30 pm - 5:45 pm	Closing Comment and Future Plans Michael T. Lotze, MD, University of Pittsburgh Cancer Institute

All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.